Added to YB: 2017-05-16
Pitch date: 2017-05-16
ATLN:SW [bullish]
Actelion Ltd
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Actelion Ltd, a biopharmaceutical company, discovers, develops, and commercializes low molecular weight drugs for unmet medical needs.
Market Cap
CHF 28.8B
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
41.97
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
ACTELION LTD ORD ATLN:SW
A summary for this pitch has not been created yet.
Read full article (0 min)